Glooscap First Nation Nears Key Indigenous Cannabis Regulation Decision
Indigenous cannabis regulation is advancing as Glooscap First Nation approaches a significant decision. This development impacts patient access and clinical frameworks. Clinicians must understand indigenous cannabis regulation to provide informed care.
Advisory Council Urges Regulation of North Carolina’s Cannabis Market
North Carolina cannabis market regulation is gaining attention as the advisory council recommends oversight of the unregulated market. This move aims to improve product safety and quality control for patients and clinicians. Regulatory frameworks will…
First Alabama Medical Cannabis Dispensary to Open Next Month – Ganjapreneur
The first Alabama medical cannabis dispensary open next month represents a significant milestone in cannabis medicine. This development has important clinical implications for practitioners and patients alike. Clinicians should monitor this evolving area…
California Must Keep Its Promise to Protect Kids from Big Cannabis
California cannabis enforcement challenges pose risks to adolescent access and youth protection efforts. Regulatory gaps undermine promised safeguards against high-potency cannabis exposure. Clinicians must stay informed to counsel youth effectively on…
California Must Keep Its Promise to Protect Kids from Big Cannabis
California cannabis policy updates are critical to safeguarding youth from the influence of big cannabis. This page highlights key developments in 2026 legislation. Clinicians and policymakers should monitor these updates closely.
Poll: Pennsylvanians Across Party Lines Support a Regulated Cannabis Marketplace
A recent poll highlights strong support for a regulated cannabis marketplace across party lines in Pennsylvania. This regulated cannabis marketplace reflects growing public interest in cannabis policy. Clinicians and policymakers should consider these…
Maine’s Need for Enhanced Contaminant Testing in Medical Cannabis
2026 cannabis testing standards are critical for ensuring the safety of medical cannabis in Maine. Contaminant testing helps protect patients from harmful substances. This article highlights the need for improved testing protocols in Maine's medical…
Current state of hemp and cannabis
The FDA’s still deciding whether cannabis is medicine or Schedule I contraband, while patients quietly self-titrate in states where it’s apparently more legal than aspirin. Clinical evidence moves slower than the regulatory apparatus, which…
MMJ International Holdings Seeks Injunction to Halt CMS CBD Program | Newswire
MMJ International Holdings has filed for a cms cbd program injunction to block a Centers for Medicare and Medicaid Services initiative. This legal action raises critical questions about regulatory oversight of cannabidiol products in Medicare. The…
Cannabis Companies Pull Back Investments in Hartford Amid Market Changes
Connecticut cannabis market pullback reflects regulatory challenges impacting patient access to cannabis products. Companies are reducing investments amid market uncertainties. Clinicians should monitor these changes to support patient care.